Gossamer Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.17

-0.01 (-6.15%)

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 57%

Hold 5 36%

Sell 1 7%

Price Target

Analyst Price Target +16,215.5% upside

Low Target $18.46

Average Target $27.41

High Target $44.08

Current Price $0.17

Current
$0.17

Target
$27.41

$18.46 $27.41 avg $44.08

Scenario Analysis

Bear Case

$18.46

10,888.1%

Low target

Base Case

$27.41

+16,215.5%

Avg target

Bull Case

$44.08

+26,138.1%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$3.87

-95.7% from high

52-Week Low

$0.14

+20.0% from low

Target vs 52W High

$27.41

+608.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%